Global Lab Automation Market Set To Grow To $6.3bn By 2022

02 August 2018
Pharma

Visiongain’ has launched a new pharma report Global Lab Automation Market Forecast 2018-2028: Modular Automation, Total Lab Automation, Automated Liquid Handling, Microplate Readers, Software & Informatics, Automated Storage & Retrieval Systems, Automated Integrated Workstations, Reagent Dispensers, Microplate Washers, Multi-mode, Single-mode, Laboratory Information Management System, Electronic Laboratory Notebook, Scientific Data Management Systems, Drug Discovery, Clinical Diagnostics, Genomic Solutions, Proteomic Solutions, Others

Laboratory automation system includes automated lab instruments, software and devices which offer benefits such as reduction of cycle time, increasing productivity, improvement of workflow coverage and improvement of data quality. The laboratory automation or robotic products are offered in modified form, according to the necessity of specific laboratories or researcher. Therefore, lab automation becomes essential in laboratories for handling high volumes of sample at faster rate. This system offers smooth solution to lab procedures such as decapping, centrifugation, aliquoting, recapping and sorting among others.

The lead analyst of the report commented “In 2017, the automated liquid handling submarket held the largest market share in the global lab automation market. Growth in this market is set to be driven by the precision and accuracy offered, reduced cost of labour and the availability of a wide range of application.

The microplate readers submarket is expected to grow at the highest CAGR in the forecast period from 2018 to 2028. The growth of this submarket is driven by ease of use, as well as combination of multiple measurement technologies such as absorbance, fluorescence, and luminescence into one compact instrument.”

Leading companies featured in the report include Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Holding AG, Siemens Healthineers, Qiagen N.V., PerkinElmer, Inc., Agilent Technologies, Abbott Laboratories, Tecan Trading AG, Labcyte, Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever